Beck Mack & Oliver’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.12M Sell
55,365
-5
-0% -$728 0.16% 60
2026
Q1
$8M Buy
55,370
+3,432
+7% +$520K 0.16% 60
2025
Q4
$7.44M Sell
51,938
-220
-0.4% -$32.4K 0.14% 60
2025
Q3
$8.01M Buy
52,158
+220
+0.4% +$34.4K 0.15% 60
2025
Q2
$8.27M Buy
51,938
+247
+0.5% +$40.3K 0.16% 61
2025
Q1
$8.81M Buy
51,691
+760
+1% +$127K 0.18% 61
2024
Q4
$8.54M Sell
50,931
-318
-0.6% -$54.2K 0.16% 63
2024
Q3
$8.88M Sell
51,249
-260
-0.5% -$44.1K 0.17% 60
2024
Q2
$8.49M Buy
51,509
+195
+0.4% +$31.9K 0.18% 61
2024
Q1
$8.33M Buy
51,314
+347
+0.7% +$54.4K 0.17% 61
2023
Q4
$7.47M Sell
50,967
-25
-0% -$3.7K 0.17% 59
2023
Q3
$7.44M Sell
50,992
-2,450
-5% -$374K 0.19% 57
2023
Q2
$8.11M Sell
53,442
-1,034
-2% -$156K 0.21% 57
2023
Q1
$8.1M Sell
54,476
-1,050
-2% -$150K 0.23% 55
2022
Q4
$8.42M Sell
55,526
-42
-0.1% -$5.89K 0.25% 56
2022
Q3
$7.01M Sell
55,568
-810
-1% -$115K 0.23% 58
2022
Q2
$8.11M Sell
56,378
-260
-0.5% -$39.1K 0.24% 58
2022
Q1
$8.65M Sell
56,638
-3,533
-6% -$553K 0.22% 58
2021
Q4
$9.84M Sell
60,171
-51
-0.1% -$7.57K 0.23% 56
2021
Q3
$8.42M Sell
60,222
-3,665
-6% -$519K 0.22% 55
2021
Q2
$8.62M Buy
63,887
+635
+1% +$85.9K 0.23% 56
2021
Q1
$8.57M Sell
63,252
-2,670
-4% -$348K 0.26% 58
2020
Q4
$9.17M Sell
65,922
-3,301
-5% -$461K 0.3% 53
2020
Q3
$9.62M Sell
69,223
-2,116
-3% -$281K 0.35% 53
2020
Q2
$8.53M Sell
71,339
-650
-0.9% -$75.8K 0.32% 53
2020
Q1
$7.92M Sell
71,989
-1,769
-2% -$212K 0.35% 50
2019
Q4
$9.21M Sell
73,758
-1,083
-1% -$133K 0.3% 57
2019
Q3
$9.31M Buy
74,841
+747
+1% +$88.3K 0.33% 56
2019
Q2
$8.12M Sell
74,094
-2,211
-3% -$236K 0.29% 57
2019
Q1
$7.94M Sell
76,305
-4,465
-6% -$435K 0.28% 57
2018
Q4
$7.42M Sell
80,770
-7,686
-9% -$687K 0.3% 56
2018
Q3
$7.36M Sell
88,456
-5,286
-6% -$432K 0.23% 61
2018
Q2
$7.32M Sell
93,742
-629
-0.7% -$47.3K 0.25% 61
2018
Q1
$7.48M Sell
94,371
-9,698
-9% -$809K 0.25% 59
2017
Q4
$9.56M Sell
104,069
-1,992
-2% -$179K 0.31% 57
2017
Q3
$9.65M Buy
106,061
+6,069
+6% +$553K 0.32% 60
2017
Q2
$8.71M Sell
99,992
-875
-0.9% -$77.1K 0.29% 61
2017
Q1
$9.06M Sell
100,867
-1,770
-2% -$157K 0.32% 62
2016
Q4
$8.63M Sell
102,637
-83
-0.1% -$7.07K 0.31% 63
2016
Q3
$9.22M Sell
102,720
-5,271
-5% -$458K 0.33% 61
2016
Q2
$9.14M Buy
107,991
+186
+0.2% +$15.3K 0.32% 60
2016
Q1
$8.87M Sell
107,805
-5,559
-5% -$448K 0.31% 63
2015
Q4
$9M Sell
113,364
-4,854
-4% -$371K 0.31% 64
2015
Q3
$8.5M Sell
118,218
-4,930
-4% -$370K 0.26% 63
2015
Q2
$9.64M Sell
123,148
-2,647
-2% -$213K 0.25% 64
2015
Q1
$10.3M Sell
125,795
-1,462
-1% -$126K 0.26% 64
2014
Q4
$11.6M Buy
127,257
+940
+0.7% +$82.7K 0.28% 61
2014
Q3
$10.6M Buy
126,317
+17
+0% +$1.39K 0.25% 63
2014
Q2
$9.93M Sell
126,300
-5,495
-4% -$443K 0.22% 64
2014
Q1
$10.6M Sell
131,795
-4,329
-3% -$341K 0.25% 61
2013
Q4
$11.1M Sell
136,124
-851
-0.6% -$69.3K 0.27% 61
2013
Q3
$10.4M Sell
136,975
-3,324
-2% -$265K 0.27% 59
2013
Q2
$10.8M Buy
+140,299
New +$11M 0.29% 59

Other funds holding PG

Beck Mack & Oliver's PG Position: Q2 2026 in Review

Beck Mack & Oliver reduced its Procter & Gamble (PG) stake by 0.01% in Q2 2026, selling an estimated $728 and leaving 55,365 shares worth $8.12M. The position accounts for 0.16% of the portfolio, ranked #60.

Beck Mack & Oliver first reported a position in PG in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.6M in Q4 2014. 3,999 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Beck Mack & Oliver held 55,365 shares of Procter & Gamble worth $8.12M as of Q2 2026.
  • Beck Mack & Oliver sold 5 Procter & Gamble shares in Q2 2026, an estimated $728.
  • Procter & Gamble made up 0.16% of Beck Mack & Oliver's portfolio in Q2 2026, its #60 holding.
  • Beck Mack & Oliver first reported a position in Procter & Gamble in Q2 2013 and has held it in 53 quarters since.
  • Beck Mack & Oliver's Procter & Gamble position peaked at $11.6M in Q4 2014.
  • 3,999 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Beck Mack & Oliver's 13F filing for Q2 2026, filed 14 Aug 2026.